Oxford Instruments on Track for Full-Year Targets as Advanced Technologies Orders Surge

The latest update is out from Oxford Instruments ( (GB:OXIG) ).

Oxford Instruments said trading for the three months to 31 December 2025 keeps the group on course to meet full‑year market expectations for adjusted operating profit, supported by a year‑to‑date book‑to‑bill ratio of 1.2 and ongoing order growth across its divisions. Imaging and Analysis orders rose 2.4% on an organic constant currency basis versus the prior year’s third quarter, with earlier restructuring in its Belfast imaging operations now delivering expected second‑half benefits, while Advanced Technologies continued to post strong momentum, with year‑to‑date orders up 44.5% and an order book stretching well into fiscal 2027. The group completed the sale of its NanoScience business on 2 January 2026, generating £48.5m in net cash, has effectively de‑risked its defined benefit pension through a buy‑in that will end company contributions after FY26, and is progressing a £100m share buyback, of which £41.2m of the first £50m tranche was completed by year‑end, even as currency headwinds are still expected to trim about £5.5m from FY26 adjusted operating profit compared with the prior year.

The most recent analyst rating on (GB:OXIG) stock is a Buy with a £2430.00 price target. To see the full list of analyst forecasts on Oxford Instruments stock, see the GB:OXIG Stock Forecast page.

Spark’s Take on GB:OXIG Stock

According to Spark, TipRanks’ AI Analyst, GB:OXIG is a Outperform.

Oxford Instruments demonstrates robust financial performance and positive corporate actions, supporting a strong position in the semiconductor industry. However, high valuation metrics and potential overbought technical indicators suggest caution. The company’s strategic initiatives and positive earnings outlook are significant strengths, but liquidity and profitability challenges need to be addressed.

To see Spark’s full report on GB:OXIG stock, click here.

More about Oxford Instruments

Oxford Instruments is a FTSE 250-listed provider of market‑leading scientific technology tools and expertise to academic and commercial customers worldwide, with core market segments in materials analysis, semiconductors, and healthcare and life sciences. Founded in 1959 as the first technology spin-out from Oxford University, the company positions itself at the intersection of academic research and commercial application, targeting growth from rising global R&D investment in new materials, productivity and decarbonisation technologies.

Average Trading Volume: 169,184

Technical Sentiment Signal: Buy

Current Market Cap: £1.21B

See more insights into OXIG stock on TipRanks’ Stock Analysis page.